Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE0005659700
Mon, 27.09.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 27 September 2021. The Centre Hospitalier Universitaire de Nantes (CHU), the French university hospital serving the greater Nantes/Saint-Nazaire metropolitan area, has started to dose first patients with PENTIXAFOR, an innovative imaging compound for the initial staging of cancer patients with symptomatic multiple myelomas. The Ga-68 based [ … ]
Thu, 26.08.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 26 August 2021. Eckert & Ziegler (ISIN DE0005659700, TecDAX), has started the delivery of Technetium-99 generators in Brazil. The subsidiary Eckert & Ziegler Brasil Comercial Ltda. had recently received a license from the Brazilian health authority ANVISA as the first and only private company to import and distribute technetium gene [ … ]
Thu, 12.08.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 12 August 2021. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), achieved a new record result in the first half of 2021 with a net profit of € 22.3 million or € 1.08 per share. Revenues of the Group amounted to € 89.5 million and were thus 7% above the previous year's level.
Although a large part of this gro [ … ]
Mon, 09.08.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, August 9, 2021. Eckert & Ziegler Radiopharma GmbH in Braunschweig, a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), has now received manufacturing authorization from the Lower Saxony authorities for several thorium and lutetium compounds in accordance with the German Medicines Act. This a [ … ]
Mon, 02.08.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 2 August 2021. Eckert & Ziegler (ISIN DE0005659700, TecDAX) acquired Ambientis Radioproteção, based in Sao Paulo, Brazil, effective July 31st, 2021 via its subsidiary Eckert & Ziegler Brasil Isotope Solutions Ltda (EZBIS). The business with annual sales in the low single-digit million range and 24 employees and specialists have been [ … ]
Tue, 08.06.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 8 June 2021 - Myelo Therapeutics GmbH, an affiliate of Eckert & Ziegler (ISIN DE0005659700, TecDAX) focused on developing medical countermeasures (MCM) and therapies for cancer supportive care, announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, extended their [ … ]
Thu, 03.06.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 3 June 2021. Eckert & Ziegler (ISIN DE0005659700, TecDAX) and Telix Pharmaceuticals (Telix) will cooperate closely in the commercialization of GalliaPharm(R) (68Ge/68Ga Generator) and investigational product Illuccix(R) (Kit for the preparation of Ga-68 PSMA-11 injection) in the United States. An agreement to this effect has now been si [ … ]
Tue, 18.05.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 18.05.2021. Eckert & Ziegler (ISIN DE0005659700, TecDAX) has signed an agreement with Telix Pharmaceuticals (Telix), an Australian-headquartered company, for the exclusive distribution of Illuccix(R) (Kit for the preparation of Ga-68 PSMA-11 injection) in Germany. Illuccix(R) is a preparation for imaging prostate cancer with positron em [ … ]
Mon, 17.05.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 17 May 2021. One-off effects from the deconsolidation of the tumor irradiation business, a waning of the Corona slump, and continued strong demand in particular for pharmaceutical radioisotopes more than doubled net profit at Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700; TecDAX) in the first quarter of 2021. With [ … ]
Wed, 28.04.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 28 April 2021. Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) and Sirtex Medical (Sirtex) have executed a long-term supply agreement for the use of EZAG's Yttrium-90 in Sirtex SIR-Spheres(R) Y-90 resin microspheres for liver cancer. The arrangement has an initial term of five years and guarantees Eckert & Ziegler a substantial shar [ … ]